Literature DB >> 12365578

Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment.

H Ramarokoto1, H Randriamiharisoa, A Rakotoarisaonina, T Rasolovavalona, V Rasolofo, S Chanteau, M Ralamboson, B Cauchoix, D Rakotondramarina.   

Abstract

SETTING: Significance of a positive bacillary examination of sputum at 2 months of treatment in relation to the viability of the bacilli and the final treatment result.
OBJECTIVE: To compare the results of smear microscopy and sputum culture at the second month of tuberculosis treatment and to follow the progress of the patients.
METHODS: Follow-up of 297 patients with smear-positive pulmonary tuberculosis in Madagascar, 152 of whom were smear-positive at 2 months of treatment and 145 smear-negative. The number of bacilli was recorded, as were the culture results and the final outcome of treatment.
RESULTS: Among the 152 patients who were smear-positive at the second month, 77 (51%) were culture-negative; there were 12 (8%) treatment failures and four relapses (4.6%). Among the 145 smear-negative patients, 22 (15%) were culture-positive, of which one was a treatment failure (1%).
CONCLUSION: The majority of failures and relapses were observed in the group of smear-positive patients. It is important to reinforce the surveillance of these patients in order to reduce the number lost to follow-up. Furthermore, a positive smear microscopy at the end of the second month is not sufficiently specific for early identification of treatment failures. It is preferable to wait until the fifth month, as the great majority of patients who are positive at 2 months achieve cure. The treatment strategy currently recommended in Madagascar is satisfactory.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12365578

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  13 in total

1.  Application of oxidation-reduction assay for monitoring treatment of patients with pulmonary tuberculosis.

Authors:  Parissa Farnia; Foroazan Mohammadi; Mehdi Mirsaedi; Abolhasan Zia Zarife; Javad Tabatabee; Katayoon Bahadori; Muslem Bahadori; Mohammad Reza Masjedi; Ali Akbar Velayati
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  Cetyl-pyridinium chloride is useful for isolation of Mycobacterium tuberculosis from sputa subjected to long-term storage.

Authors:  Manuela Pardini; Francis Varaine; Elisabetta Iona; Erchanik Arzumanian; Francesco Checchi; Marco Rinaldo Oggioni; Graziella Orefici; Lanfranco Fattorini
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

Review 3.  Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

Authors:  David J Horne; Sarah E Royce; Lisa Gooze; Masahiro Narita; Philip C Hopewell; Payam Nahid; Karen R Steingart
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

4.  Usefulness of the BACTEC MGIT 960 system for isolation of mycobacterium tuberculosis from sputa subjected to long-term storage.

Authors:  Manuela Pardini; Francis Varaine; Maryline Bonnet; Graziella Orefici; Marco Rinaldo Oggioni; Lanfranco Fattorini
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

5.  Non-conversion of sputum culture among patients with smear positive pulmonary tuberculosis in Cameroon: a prospective cohort study.

Authors:  Eric Walter Pefura-Yone; André Pascal Kengne; Christopher Kuaban
Journal:  BMC Infect Dis       Date:  2014-03-11       Impact factor: 3.090

6.  Five-year assessment of time of sputum smears conversion and outcome and risk factors of tuberculosis patients in central iran.

Authors:  Fatemah Behnaz; Mahmoud Mohammadzadeh; Golnaz Mohammadzade
Journal:  Tuberc Res Treat       Date:  2015-01-14

7.  Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting.

Authors:  Natasha Van't Boveneind-Vrubleuskaya; Alper Daskapan; Jos G W Kosterink; Tjip S van der Werf; Susan van den Hof; Jan-Willem C Alffenaar
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

8.  The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis.

Authors:  Martine G Aabye; Pernille Ravn; George PrayGod; Kidola Jeremiah; Apolinary Mugomela; Maria Jepsen; Daniel Faurholt; Nyagosya Range; Henrik Friis; John Changalucha; Aase B Andersen
Journal:  PLoS One       Date:  2009-01-19       Impact factor: 3.240

9.  Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil.

Authors:  Maria do Socorro Nantua Evangelista; Rosalia Maia; João Paulo Toledo; Ricardo Gadelha de Abreu; José Uereles Braga; Draurio Barreira; Anete Trajman
Journal:  BMC Res Notes       Date:  2018-06-28

10.  Additional benefits of GeneXpert MTB/RIF assay for the detection of pulmonary tuberculosis patients with prior exposure to fluoroquinolones.

Authors:  Peijun Tang; Ping Xu; Wei Shu; Xiafang Wang; Jian Guo; Huafeng Song; Sumei Li; Yu Pang; Meiying Wu
Journal:  Infect Drug Resist       Date:  2018-12-27       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.